机构：[1]State Key Laboratory of Biotherapy and Cancer Center, Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China四川大学华西医院[2]Chongqing Institute of Health Resources Innovation, Chongqing 400039, China[3]Department of Hematology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China四川大学华西医院[4]Blood Research Laboratory, Chengdu Blood Center, Chengdu 610020, China[5]Department of Obstetrics and Gynecology, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China四川省人民医院[6]Hematology Department, The General Hospital of Western Theater Command, PLA, Chengdu 610083, China西部战区总医院[7]Frontiers Medical Center, Tianfu Jincheng Laboratory, Chengdu 610212, China
This work was supported by the the National Key Research and Development
Program of China (2023YFC3403303 and 2023YFC3403304); National Natural
Science Foundation of China (32471551); the 1⋅3⋅5 Project for Disciplines of
Excellence, West China Hospital, Sichuan University (ZYJC21003); Tianfu
Jincheng Laboratory Foundation (TFJC2023010006); the Major Scientific
and Technological Achievements Transformation Project of Ningxia Hui
Autonomous Region (2022CJE09013); the Weigao Research Fund of the Chinese Blood Transfusion Association (CSBT-WG-2024-09); the Postdoctoral
Fellowship Program of CPSF (GZC20241136); the Postdoctoral Research
Fund of West China Hospital, Sichuan University (2024HXBH097); and the Sichuan Science and Technology Program (2025ZNSFSC1693).
第一作者机构：[1]State Key Laboratory of Biotherapy and Cancer Center, Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China[2]Chongqing Institute of Health Resources Innovation, Chongqing 400039, China
共同第一作者：
通讯作者：
通讯机构：[1]State Key Laboratory of Biotherapy and Cancer Center, Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China[7]Frontiers Medical Center, Tianfu Jincheng Laboratory, Chengdu 610212, China
推荐引用方式(GB/T 7714)：
Yang Chen,Wang Ping,Yang Mingjun,et al.A nanobody-based tri-specific NK cell engager targeting CD5 triggers antitumor immunity[J].Cell Reports. Medicine.2025,6(10):102409.doi:10.1016/j.xcrm.2025.102409.
APA：
Yang Chen,Wang Ping,Yang Mingjun,Lu Huaqing,Lu Qizhong...&Tong Aiping.(2025).A nanobody-based tri-specific NK cell engager targeting CD5 triggers antitumor immunity.Cell Reports. Medicine,6,(10)
MLA：
Yang Chen,et al."A nanobody-based tri-specific NK cell engager targeting CD5 triggers antitumor immunity".Cell Reports. Medicine 6..10(2025):102409
医学